Postprandial Hyperglycemia and Cardiovascular Disease: Is the HEART2D study the answer?

Por Ceriello, Antonio
Publicado em 2009

Point: Postprandial Glucose Levels Are a Clinically Important Treatment Target

Por Ceriello, Antonio
Publicado em 2010

Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes

Por Ceriello, Antonio, Testa, Roberto
Publicado em 2009

Glycemic Variability: Both Sides of the Story

Por Ceriello, Antonio, Kilpatrick, Eric S.
Publicado em 2013

Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations

Por Ceriello, Antonio, Inagaki, Nobuya
Publicado no J Diabetes Investig (2016)

Postprandial Hyperglycemia and Glycemic Variability: Should we care?

Por Standl, Eberhard, Schnell, Oliver, Ceriello, Antonio
Publicado em 2011

Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?

Por Gentile, Sandro, Strollo, Felice, Ceriello, Antonio
Publicado no Diabetes Ther (2016)

Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes

Por Gentile, Sandro, Strollo, Felice, Ceriello, Antonio
Publicado no Int J Endocrinol Metab (2016)

Cardiovascular guidelines: separate career may help attenuate controversy

Por Esposito, Katherine, Ceriello, Antonio, Genovese, Stefano, Giugliano, Dario
Publicado em 2014

Glucagon and heart in type 2 diabetes: new perspectives

Por Ceriello, Antonio, Genovese, Stefano, Mannucci, Edoardo, Gronda, Edoardo
Publicado no Cardiovasc Diabetol (2016)

Current perspectives on cardiovascular outcome trials in diabetes

Por Schnell, Oliver, Rydén, Lars, Standl, Eberhard, Ceriello, Antonio
Publicado no Cardiovasc Diabetol (2016)

Acute hyperglycemia induces an oxidative stress in healthy subjects

Por Marfella, Raffaele, Quagliaro, Lisa, Nappo, Francesco, Ceriello, Antonio, Giugliano, Dario
Publicado em 2001

Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists

Por Uccellatore, Annachiara, Genovese, Stefano, Dicembrini, Ilaria, Mannucci, Edoardo, Ceriello, Antonio
Publicado no Diabetes Ther (2015)

Type 1 diabetes and cardiovascular disease

Por Schnell, Oliver, Cappuccio, Francesco, Genovese, Stefano, Standl, Eberhard, Valensi, Paul, Ceriello, Antonio
Publicado em 2013

The Possible Role of Flavonoids in the Prevention of Diabetic Complications

Por Testa, Roberto, Bonfigli, Anna Rita, Genovese, Stefano, De Nigris, Valeria, Ceriello, Antonio
Publicado no Nutrients (2016)

Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials

Por Giugliano, Dario, Maiorino, Maria Ida, Bellastella, Giuseppe, Chiodini, Paolo, Ceriello, Antonio, Esposito, Katherine
Publicado em 2011

The Possible Protective Role of Glucagon-Like Peptide 1 on Endothelium During the Meal and Evidence for an “Endothelial Resistance” to Glucagon-Like Peptide 1 in Diabetes

Por Ceriello, Antonio, Esposito, Katherine, Testa, Roberto, Bonfigli, Anna Rita, Marra, Maurizio, Giugliano, Dario
Publicado em 2011

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress

Por Ceriello, Antonio, La Sala, Lucia, De Nigris, Valeria, Pujadas, Gemma, Rondinelli, Maurizio, Genovese, Stefano
Publicado no Ther Clin Risk Manag (2015)

Short-term high glucose exposure impairs insulin signaling in endothelial cells

Por De Nigris, Valeria, Pujadas, Gemma, La Sala, Lucia, Testa, Roberto, Genovese, Stefano, Ceriello, Antonio
Publicado no Cardiovasc Diabetol (2015)

Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin

Por Rabbani, Naila, Chittari, Madhu Varma, Bodmer, Charles W., Zehnder, Daniel, Ceriello, Antonio, Thornalley, Paul J.
Publicado em 2010